Crossmark

Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society

Crossref DOI link: https://doi.org/10.1016/j.endien.2025.101523

Published Print: 2025-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pedro-Botet, Juan

Arrieta, Francisco

Botana, Manuel

Gimeno-Orna, José A.

Martínez-Montoro, José I.

Ortega-Martínez de Victoria, Emilio

Ribalta, Josep

Sánchez-Margalet, Víctor

Pérez-Pérez, Antonio
License Information

Text and Data Mining valid from 2025-02-01

Text and Data Mining valid from 2025-02-01
More Information

This article is maintained by: Elsevier

Article Title: Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2025.101523

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.endinu.2024.09.001

Content Type: article

Copyright: © 2024 SEEN and SED. Published by Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Document is current

Any future updates will be listed below